Stereotactic aspiration for brain stem bleeding
Part of Brain & nervous system, Injuries & trauma clinical trials.
This trial tests a minimally invasive surgery to drain blood from a bleed in the brain stem. It aims to reduce pressure and improve recovery in patients with severe bleeding who arrive at the hospital quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a bleed in the brain stem larger than 5 ml, confirmed by CT or MRI scan.
- You arrive at the hospital and get diagnosed within 24 hours of the bleed starting.
- Your level of consciousness is very low (GCS score 4-8), meaning you are in a coma or near coma.
- You have severe neurological problems (NIHSS score of 21 or higher).
- You are between 18 and 65 years old.
- You are breathing on your own when you arrive at the hospital.
- You do not have bleeding caused by other conditions like a malformed blood vessel, tumor, or recent use of blood-thinning medications.
- You are healthy enough to complete a 3-month follow-up after the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a minimally invasive surgery guided by a robotic AI system can help people with moderate bleeding deep inside the brain (basal ganglia). If you qualify, the surgery would happen within 72 hours of your stroke.
This trial tests a new, less invasive brain surgery using a robotic arm guided by artificial intelligence (AI) to remove a large blood clot caused by a hemorrhagic stroke in the basal ganglia. It may be an option for people who can have surgery soon after the stroke and were previously independent.
This trial tests a minimally invasive surgery guided by artificial intelligence to treat spontaneous brain bleeding. It aims to improve recovery by precisely removing the clot with less damage to healthy brain tissue.
This trial tests a new, less invasive surgery using a robot to help guide the doctor to drain blood from a brainstem bleed. It may be an option for people who can have surgery soon after the bleed and who have a certain level of consciousness.
This trial studies whether a minimally invasive, image-guided endoscopic procedure can remove blood after a specific type of brain bleed. It may help reduce symptoms and improve outcomes compared with standard care, but you must meet timing and medical criteria.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
Hear when a new Brain Stem Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.